News2 February 2022 Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials Castor announces the launch of its CRO Partnership program designed to increase adoption of decentralized clinical trials and... Learn more
Webinar Executive interview with Derk Arts at Fierce JPM Week 2022 Watch this webinar for pandemic lessons the healthcare industry learned that can help tackle longtime challenges in clinical... Learn more
White papers & guides27 January 2022 DTx Clinical Trials and Data Standardization In this paper, Castor explores the benefits and challenges of Digital Therapeutics (DTx) trials and provides recommendations on... Learn more
Blog25 January 2022 Bridging clinical efficacy and real-world effectiveness in digital therapeutics trials Tech tools help Digital Therapeutics (DTx) maximize the impact of the real-world data they capture, explore how in... Learn more
White papers & guides21 January 2022 Choosing Your Best Route to DTx Commercialization In this guide, Castor discusses routes to digital therapeutics commercialization and tools to meet the challenges on the... Learn more
White papers & guides18 January 2022 Navigating the DTx Regulatory Landscape The regulations around digital therapeutics (DTx) are constantly changing. Learn how DTx providers are trying to overcome these... Learn more
Webinar Effortless hybrid consent with Castor eConsent Designed for decentralized, hybrid, and traditional research projects, Castor’s eConsent solution delivers compliant, site-friendly & participant-centric trial onboarding... Learn more
Blog5 January 2022 Today’s Challenges for Digital Therapeutics Digital Therapeutics (DTx) is a rapidly growing space whose players are facing challenges in scaling their businesses, including... Learn more
Blog17 December 2021 Regulating Digital Therapeutic Cybersecurity: Today and Tomorrow Cybersecurity has become a concern for Digital Therapeutics (DTx) developers and regulatory bodies. Learn to balance functionality &... Learn more
News16 December 2021 Castor Delivers Strong Finish to 2021, Continues Expansion into US Market Castor announced transformative growth with anticipated topline acceleration driven by the company’s momentous US market expansion Learn more
News9 December 2021 Castor named to the 2021 CB Insights Digital Health 150 – List of Most Innovative Digital Health Startups CB Insights named Castor to its third annual Digital Health 150, which showcases the 150 most promising private... Learn more
White papers & guides29 November 2021 Getting Started with DCT in 2022 Castor advisor Craig Lipset, suggests that you consider DCT technology as three separate tiers. Learn more about these... Learn more
Blog19 November 2021 How to Incorporate Remote Technology in Your Next Medical Device Trial Researchers are looking to incorporate remote technologies into medical device trials for a wide range of device classifications.... Learn more
White papers & guides12 November 2021 Overview of EU Medical Device Regulations Medical device regulations in the EU have recently undergone a major overhaul. Learn the key tenets of MDR... Learn more
News8 November 2021 Castor Appoints Digital Leader Milind Kamkolkar to Board of Directors Industry veteran Milind Kamkolkar joins Castor’s Board of Directors to advance mission of democratizing clinical research by maximizing... Learn more
White papers & guides2 November 2021 How Medical Device Trials Can Benefit From Decentralized Methods In this whitepaper, we will look at how EDC, eConsent, ePRO, and APIs enable researchers to easily conduct... Learn more
News1 November 2021 Castor is accelerating global medical device research with decentralized clinical trials platform Castor’s DCT platform helping medical device trials achieve compliance with patient-focused technology Driving innovation for medical device clinical... Learn more
White papers & guides19 October 2021 Capturing and Managing Data in DTx Trials Download this whitepaper to gain a comprehensive overview of DTx, its regulatory landscape, and routes to commercialization. Learn more
